Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 1,187 | 155 | 1,016 |
| Samples | 386 | 72 | 307 |
| Peptides | 322 | 47 | 274 |
Function
TRIM37 · Tripartite motif containing 37
This gene encodes a member of the tripartite motif (TRIM) family, whose members are involved in diverse cellular functions such as developmental patterning and oncogenesis. The TRIM motif includes zinc-binding domains, a RING finger region, a B-box motif and a coiled-coil domain. The RING finger and B-box domains chelate zinc and might be involved in protein-protein and/or protein-nucleic acid interactions. Mutations in this gene are associated with mulibrey (muscle-liver-brain-eye) nanism, an autosomal recessive disorder that involves several tissues of mesodermal origin. TRIM37 localizes in peroxisomal membranes, and has been implicated in human peroxisomal biogenesis disorders. [provided by RefSeq, Jul 2020].
Isoforms & Proteins
5 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 314 amino-acid changes on canonical ENST00000262294 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in TRIM37 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TRIM37 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Endometrial Carcinoma | 9/42 21% | 22/612 4% |
| Acute Myeloid Leukemia | 2/90 2% | 0/0 0% |
| Melanoma | 2/210 1% | 44/1899 2% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Colorectal Carcinoma | 16/143 11% | 49/3239 2% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 15/810 2% |
| Gastric Carcinoma | 6/74 8% | 25/1809 1% |
| Non-Small Cell Lung Carcinoma | 6/304 2% | 19/1390 1% |
| Bladder Carcinoma | 0/58 0% | 14/956 1% |
| Cervical Carcinoma | 0/35 0% | 5/422 1% |
| Osteosarcoma | 2/45 4% | 0/166 0% |
| Other Solid Cancers | 3/94 3% | 12/1515 1% |
| Wilms Tumour | 0/5 0% | 4/474 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 6/752 1% |
| Esophageal Carcinoma | 2/23 9% | 4/769 1% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 1/133 1% |
| Head and Neck Carcinoma | 4/85 5% | 8/1574 1% |
| Hepatocellular Carcinoma | 3/46 7% | 11/2210 0% |
| Thyroid Gland Carcinoma | 1/45 2% | 9/1592 1% |
| Neuroendocrine Tumour | 4/154 3% | 0/577 0% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Rhabdomyosarcoma | 0/33 0% | 1/171 1% |
| Breast Carcinoma | 3/144 2% | 13/3264 0% |
| Mesothelioma | 1/62 2% | 0/165 0% |
| Burkitts Lymphoma | 0/32 0% | 1/196 1% |
| Other Sarcomas | 2/69 3% | 1/699 0% |
| Esophageal Squamous Cell Carcinoma | 1/51 2% | 9/2550 0% |
| Ovarian Carcinoma | 1/109 1% | 3/998 0% |
| Pancreatic Carcinoma | 2/89 2% | 4/1611 0% |
| Glioma | 0/52 0% | 7/2127 0% |
Mutation Distribution
Where TRIM37 is mutated · all tissues, split by cell line vs tissue
How many mutations in TRIM37 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 1,187 mutations in TRIM37
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|